Blockchain Registration Transaction Record

Helus Pharma Appoints Dr. Robert Langer and Dr. Stephen Brannan to Scientific Advisory Board

Helus Pharma appoints Dr. Robert Langer and Dr. Stephen Brannan to Scientific Advisory Board, boosting expertise in drug delivery and CNS development for novel depression and anxiety treatments.

This news matters because the addition of Dr. Robert Langer and Dr. Stephen Brannan to Helus Pharma's Scientific Advisory Board signals a strong commitment to rigorous, evidence-based drug development in mental health. Their expertise could accelerate the advancement of novel serotonergic agonists, potentially offering new treatment options for millions suffering from depression and anxiety. For investors, this move enhances the company's credibility and could positively impact its pipeline's success, making it a noteworthy development in the biotech sector.